Intersect ENT Announces Appointment Of Cynthia L. Lucchese To Board of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of Cynthia L. Lucchese to the company’s board of directors. Ms. Lucchese will serve as chair of the audit committee and as a member of the nominating and governance committee.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC